The University of Chicago Cancer Research Center (UCCRC) is a formal academic unit with departmentalstatus within the Division of the Biological Sciences (BSD). The Director has department chair status and sitson the Division's governing bodies. The Director has control over administrative and research space, fiscalresponsibility for the CCSG, American Cancer Society Institutional Research Grant (ACS-IRG), caBIGcontract with NCI, philanthropic funds raised by the University of Chicago Cancer Research Foundation(UCCRF), and interdepartmental/interdisciplinary grants >$500,000 annual direct costs. The Director hasauthority over UCCRC membership and appointments, direct and shared authority over shared resources,and full authority over UCCRC philanthropic activities. Under the leadership of Dr. Marcy List, AssociateDirector for Administration, the UCCRC is responsible for managing all of these activities as they relate toboth the administrative needs of the UCCRC, and the research operations of the 198 UCCRC investigators.The UCCRC administrative unit is subdivided into seven subunits: Finances and Human Resources*,Informatics, Grant and Program Development, Clinical TrialsA, Fundraising*, Communications*, and theCancer Resource Center* (* indicates no CCSG funds requested; A described in Section 9.1.13). TheFinancial Unit (Director for Finance plus 2 additional FTE's) is responsible for all pre- and post-awardactivities for over $5.5 million (annual direct costs) in federal and non-federal grants and contracts, and $9.3million in philanthropic funds, and the allocation of UCCRC funds through RFA's. At present, the officemanages a SPORE grant, a Leukemia and Lymphoma Society SCOR, the CCSG, the ACS-IRG, caBIGcontract, and numerous foundation accounts. The Informatics Unit (Director for Informatics plus 5 additionalFTE's) is responsible for all informatics and database support for UCCRC administrative units, the CCTOand UCCRC investigators as well as coordinating UCCRC IT activities with those of the BSD and Universityof Chicago Medical Center, and supporting the UCCRC Website. Four FTE's are responsible for Grant andProgram Development Support, which includes all non-financial pre- and post-award support for largecancer-related grants (in the past 3 years, this group has been responsible for the submission of the CCSG,ACS-IRG, 4 SPORE applications, 2 SCOR applications, and 1 Tumor Microenvironment Networkapplication); coordination of program and overall UCCRC development, planning and evaluation activities;and coordination of activities related to membership and recruitment. These activities represent a significantexpansion of UCCRC responsibilities, with a parallel increase in staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-33
Application #
7714224
Study Section
Special Emphasis Panel (ZCA1-RTRB-N (J1))
Project Start
2008-07-22
Project End
2013-03-31
Budget Start
2008-07-22
Budget End
2009-03-31
Support Year
33
Fiscal Year
2008
Total Cost
$226,435
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24
Jeong, Choongwon; Witonsky, David B; Basnyat, Buddha et al. (2018) Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal. PLoS Genet 14:e1007650
Wang, Xin; Wu, Xingye; Zhang, Zhonglin et al. (2018) Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep 8:17914
Brown, Hailey M; Biering, Scott B; Zhu, Allen et al. (2018) Demarcation of Viral Shelters Results in Destruction by Membranolytic GTPases: Antiviral Function of Autophagy Proteins and Interferon-Inducible GTPases. Bioessays 40:e1700231
Karrison, Theodore; Kocherginsky, Masha (2018) Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? Clin Trials 15:178-188
An, Ningfei; Khan, Saira; Imgruet, Molly K et al. (2018) Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. Blood 131:2682-2697
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163

Showing the most recent 10 out of 668 publications